Silence Therapeutics

SLNNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$573.300 M

$12.25 +0.41%

Close of 21 Sept 2026

Revenue

$559.0K

#3528 by revenue

Earnings

-$88.6M

Loss-making

Shares outstanding

141,740,037

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#197OculisOCS$588.0M
#198Bright Minds BiosciencesDRUG$586.5M
#199Silence TherapeuticsSLN$573.3M
#200Evotec SEEVO$547.9M
#201ArvinasARVN$542.7M

What if Silence Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$646,881.50

Per share 52,807× higher

Bitcoin $1.72T

$36,747.94

Per share 3,000× higher

Nvidia $5.48T

$117,090.98

Per share 9,558× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Silence Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.